Effective and gentle activation of T cells is critical for achieving high cell count in final product while also keeping young phenotype for persistence and clinical efficacy after infusion. Selected stem like or “young” T cells can significantly influence the biological activity of the final therapy, according to FDA guidelines. Enceed™ T cell Activation Reagent is designed as a nanosized particle preconjugated with CD3 and CD28 antibodies of proprietary clone to activate T cells with ehanced memorial phenotype.
Effective and gentle activation of T cells is critical for achieving high cell count in final product while also keeping young phenotype for persistence and clinical efficacy after infusion. Selected stem like or “young” T cells can significantly influence the biological activity of the final therapy, according to FDA guidelines. Enceed™ T cell Activation Reagent is designed as a nanosized particle preconjugated with CD3 and CD28 antibodies of proprietary clone to activate T cells with ehanced memorial phenotype.
